New targets for nerve diseases, nerve regrowth: It's all in the handshake

In this month's Proceedings of the National Academy of Sciences, scientists at Johns Hopkins and the National Institutes of Health describe an important piece in the puzzle of what can go wrong in nerve-damaging disorders such as multiple sclerosis and Guillian-Barre syndrome.

They've verified a previously suspected molecular bridge between nerve cells and their surroundings which, when broken, causes nerves to deteriorate in a way apparently identical to a variety of neurodegenerative diseases. The research adds new insight on nerve disease as well as a new focus for research on stimulating nerve cell regrowth in the brain and spinal cord.

Although the studies were performed in mice, "the human versions of the molecules involved are essentially identical in structure and type," says Ronald Schnaar, Ph.D., who led the research team; "we have no reason to believe the process in people would be significantly different."

In MS and other as-yet "unsolved" nervous system diseases, the spotlight has been on myelin, the insulating material that sheaths nerve cells in layers like a burrito wrap. In the disorders, the myelin sloughs off the surface of the nerve cell and beneath it, the axon -- the elongated part of the cell that relays messages -- disintegrates.

The new research focuses on a natural linkage -- or a "molecular handshake" as one researcher calls it -- between the myelin and the axon it insulates. The handshake isn't structurally important, the researchers say; it's not what holds the myelin in place, for example. But, as in such linkages that occur in immune cells, it apparently trips a series of reactions on either side that are necessary for normal nerve behavior.

The Hopkins/NIH researchers focused on one half of the handshake, on molecules called gangliosides that extend from the surface of the nerve cell membrane. Gangliosides are a family of complex carbohydrate and lipid-b

Contact: Marjorie Centofanti
Johns Hopkins Medical Institutions

Page: 1 2 3 4

Related biology news :

1. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
2. Anticancer drug zebularine specifically targets tumor cells
3. Study suggests cell-cycle triggers might be cancer drug targets
4. Stem cell research targets cerebral palsy
5. Energy conservation targets hit by notions of comfort
6. Yale researchers discover new potential asthma therapeutic targets related to parasites and insects
7. Researchers identify two potential protein targets for new drug therapies for pancreatic cancer
8. Moving targets: when it comes to patterns, motion gets factored in
9. Computer modeling targets epidemics, bioterror
10. UT Southwestern researchers discovery may lead to gene targets for new form of contraceptive
11. Circadian clock genes may provide targets for new cancer drugs

Post Your Comments:

(Date:7/18/2020)... ... 17, 2020 , ... Commercial launch readiness is a critical stage in a ... cure or vaccine, the global economic downturn will only increase price pressures overall for ... and capturing full value from every product launch is critical. However, history shows that ...
(Date:7/2/2020)... ... July 01, 2020 , ... ... phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute ... Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... announced that it has entered into a multi-year contract with Merus N.V., ... their translational and clinical research strategy to discover and develop ground-breaking drugs. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... R3 Stem ... injections for only $3950. With 50 million stem cells total, patients may choose which ... cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical ...
(Date:7/31/2020)... TORONTO (PRWEB) , ... July 29, 2020 , ... eSource ... and inefficiencies. This webinar will cover the history of eSource, the reasons it did ... From EMR/EHR to wearables, to site source, the industry is moving towards capturing data ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new technology ... technology of its kind on the market and we were pleased that the IFT ... of traditional cultured ingredients, creating a natural way to extend the shelf life and ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using the ... pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over ... been using the zebrafish model to investigate the causes of leukaemia and its ...
Breaking Biology Technology:
Cached News: